These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 212815)

  • 21. [Rifampicin combined with ethambutol and other antitubercular agents in the treatment of patients with chronic pulmonary tuberculosis. Early results. II. Analysis of causes of treatment interruption].
    Masztalerz J
    Pneumonol Pol; 1976 Feb; 44(2):153-61. PubMed ID: 940788
    [No Abstract]   [Full Text] [Related]  

  • 22. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
    Brändli O; Haegi V; Villiger B; Bohn W; Baumann HR; Zäch R
    Schweiz Med Wochenschr; 1989 Mar; 119(10):299-305. PubMed ID: 2652281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Proceedings: Preliminary results of a 2-phase therapy with rifampicin, ethambutol and a third drug in chronic polyresistant tuberculoses].
    Neumeyer D; Anschel R; Eule H; Fichtner K; Ganguin HG; Pickroth G
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):135-8. PubMed ID: 4491710
    [No Abstract]   [Full Text] [Related]  

  • 24. [Reactivation of pulmonary tuberculosis in patients treated with rifampicin and ethambutol].
    Kuznetsova ZA
    Probl Tuberk; 1985; (12):40-2. PubMed ID: 4095097
    [No Abstract]   [Full Text] [Related]  

  • 25. [Standardized controlled antitubercular therapy and results in 755 patients].
    Wiesner B; Cramer G; Hamel U; Roth G
    Z Erkr Atmungsorgane; 1991; 177(1-2):71-5. PubMed ID: 1808855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Results of intermittent biweekly treatment with rifampicin and ethambutol in silicotuberculosis].
    Dobre V; Silaghi I; Ulbrecht L
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1979; 28(1):39-46. PubMed ID: 223222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3.
    Oka S; Sasaki M; Kobayashi T; Matsuda T
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):84-8. PubMed ID: 4649627
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparative daily followed clinical study of treatment of chronic pulmonary tuberculosis with various combinations of ethambutol and rifampicin. Daily and intermittent method].
    Gruzlica; 1975 Dec; 43(12):1067-98. PubMed ID: 1193413
    [No Abstract]   [Full Text] [Related]  

  • 29. Ambulatory intermittent rifampicin and ethambutol in the retreatment of pulmonary tuberculosis.
    Sriyabhaya N; Jittinandana A; Kecharanantana P
    J Med Assoc Thai; 1974 Nov; 57(11):551-7. PubMed ID: 4452812
    [No Abstract]   [Full Text] [Related]  

  • 30. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effectiveness of treatment with rifampicin and isoniazid in association with ethambutol or prothionamide in patients with recently detected pulmonary tuberculosis].
    Homenko AG; Ciukanov VL
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1979; 28(4):211-8. PubMed ID: 232302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment].
    Berkani M; Chaulet P; Darbyshire JH; Nunn A; Fox W
    Rev Mal Respir; 1986; 3(2):73-85. PubMed ID: 3726263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preliminary results of initial short-term chemotherapy with INH, RMP and EMB in intermittent and biphasic administration (the 3 plus 6 experiment)].
    Anastasatu C; Bercea O; Barcan F; Stinghe R; Dinulică E; Marcovici M; Cristea M; Cărpinişan L; Gheorghiu M; Iancovici O; Ghinescu S
    Ftiziologia; 1974 May; 23(3):253-64. PubMed ID: 4842931
    [No Abstract]   [Full Text] [Related]  

  • 34. [Remote results of short-term treatment of pulmonary tuberculosis with a combination of isoniazid, rifampin and ethambutol].
    Sosnowski W; Krawczyk Z; Górnicka-Wilczyńska M; Pilarska-Machowicz A; Pruszyńska S; Pawlik J; Wardowa A; Woźniak B; Tomaszkiewicz L
    Pneumonol Pol; 1980 Nov; 48(11):663-8. PubMed ID: 7255206
    [No Abstract]   [Full Text] [Related]  

  • 35. [Late results of strictly supervised treatment of patients with newly detected pulmonary tuberculosis].
    Jozefovics F; Barbu Z; Bálinth E; Lubeniţă F
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1980; 29(3):143-8. PubMed ID: 6254127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Early results of treatment of chronic pulmonary tuberculosis with rifampicin and ethambutol adminstered intermittently once or twice a week preceded by a 3-month continuous administration].
    Kost A; Moskwa Z
    Gruzlica; 1975 Aug; 43(8):719-26. PubMed ID: 1158177
    [No Abstract]   [Full Text] [Related]  

  • 37. [Bacteriological analysis of patients treated with rifampicin and ethambutol under hospital and ambulatory conditions in Poznan in the years 1969-1972 with special reference to methods of patient surveillance].
    Krukowska-Grzezińska A; Chodera B; Klimczyk M; Kańczugowski W; Kubiaczyk T
    Gruzlica; 1974 May; 42(5):420-3. PubMed ID: 4464231
    [No Abstract]   [Full Text] [Related]  

  • 38. [Results of treatment of chronically infectious patients with rifampicin in various combinations and in various models].
    Górecki R; Stanek S
    Gruzlica; 1974 May; 42(5):411-6. PubMed ID: 4464229
    [No Abstract]   [Full Text] [Related]  

  • 39. [On the effectiveness of rifampicin and ethambutol used in 3 different therapeutical schemes in drug-resistant chronic pulmonary tuberculosis].
    Andrian A; Ciobanu V; Cojocaru G; Borşaru I; Ciobanu D; Spirescu G; Roşianu D; Pescariu M
    Ftiziologia; 1971; 20(6):623-8. PubMed ID: 5162289
    [No Abstract]   [Full Text] [Related]  

  • 40. [Immediate results of strictly supervised, intermittent treatment with rifampicin and ethambutol in patients with chronic pulmonary tuberculosis].
    Josefovics F; Vojth B; Vojth V
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1977; 26(1):35-8. PubMed ID: 191889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.